Article Versions Notes

Vergara-Gómez L, Bizama C, Zhong J, Buchegger K, Suárez F, Rosa L, Ili C, Weber H, Obreque J, Espinoza K, et al. A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance. International Journal of Molecular Sciences. 2023; 24(8):7238. https://doi.org/10.3390/ijms24087238

Vergara-Gómez, Luis, Carolina Bizama, Jun Zhong, Kurt Buchegger, Felipe Suárez, Lorena Rosa, Carmen Ili, Helga Weber, Javiera Obreque, Karena Espinoza, and et al. 2023. "A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance" International Journal of Molecular Sciences 24, no. 8: 7238. https://doi.org/10.3390/ijms24087238

Vergara-Gómez, L., Bizama, C., Zhong, J., Buchegger, K., Suárez, F., Rosa, L., Ili, C., Weber, H., Obreque, J., Espinoza, K., Repetto, G., Roa, J. C., Leal, P., & García, P. (2023). A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance. International Journal of Molecular Sciences, 24(8), 7238. https://doi.org/10.3390/ijms24087238